Principal Street Partners’s Bristol-Myers Squibb BMY Stock Holding History

Principal Street Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.12M	Sell	123,497 -1,030	-0.8%	-$59.1K	1.04%	34
2026 Q1	$7.55M	Sell	124,527 -314	-0.3%	-$18.3K	1.23%	23
2025 Q4	$6.73M	Buy	124,841 +250	+0.2%	+$12K	1.14%	31
2025 Q3	$5.62M	Sell	124,591 -5,715	-4%	-$267K	0.9%	49
2025 Q2	$6.03M	Buy	130,306 +8,071	+7%	+$396K	0.59%	45
2025 Q1	$7.46M	Buy	122,235 +1,967	+2%	+$115K	1.39%	15
2024 Q4	$6.8M	Buy	120,268 +2,053	+2%	+$115K	1.34%	19
2024 Q3	$6.12M	Sell	118,215 -13,807	-10%	-$648K	1%	32
2024 Q2	$5.48M	Sell	132,022 -5,072	-4%	-$227K	0.98%	49
2024 Q1	$7.14M	Buy	137,094 +56,188	+69%	+$2.86M	1.35%	23
2023 Q4	$4.15M	Buy	80,906 +1,175	+1%	+$61.7K	1%	48
2023 Q3	$4.63M	Buy	79,731 +5,076	+7%	+$311K	0.92%	34
2023 Q2	$4.77M	Sell	74,655 -3,290	-4%	-$221K	1.13%	37
2023 Q1	$5.4M	Buy	77,945 +2,222	+3%	+$157K	1.37%	24
2022 Q4	$5.45M	Buy	75,723 +540	+0.7%	+$40.7K	1.37%	30
2022 Q3	$5.34M	Sell	75,183 -2,112	-3%	-$153K	1.42%	11
2022 Q2	$5.95M	Sell	77,295 -16,581	-18%	-$1.26M	1.54%	14
2022 Q1	$6.86M	Buy	93,876 +5,176	+6%	+$348K	1.57%	13
2021 Q4	$5.53M	Buy	88,700 +13,730	+18%	+$805K	1.33%	22
2021 Q3	$4.44M	Sell	74,970 -2,419	-3%	-$159K	1.21%	39
2021 Q2	$5.17M	Sell	77,389 -117,340	-60%	-$7.65M	1.36%	19
2021 Q1	$12.3M	Buy	194,729 +122,296	+169%	+$7.61M	1.59%	35
2020 Q4	$4.49M	Sell	72,433 -6,560	-8%	-$403K	1.38%	25
2020 Q3	$4.76M	Sell	78,993 -6,582	-8%	-$396K	1.67%	14
2020 Q2	$5.03M	Sell	85,575 -32,176	-27%	-$1.92M	1.88%	7
2020 Q1	$6.56M	Sell	117,751 -39,537	-25%	-$2.42M	2.75%	2
2019 Q4	$10.1M	Buy	157,288 +6,295	+4%	+$361K	2.25%	2
2019 Q3	$7.66M	Buy	+150,993	New	+$7.1M	1.92%	14

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Street Partners's BMY Position: Q2 2026 in Review

Principal Street Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.83% in Q2 2026, selling an estimated $59.1K and leaving 123,497 shares worth $7.12M. The position accounts for 1.04% of the portfolio, ranked #34.

Principal Street Partners first reported a position in BMY in Q3 2019 and has held it in 28 quarters since. The position peaked at $12.3M in Q1 2021. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Principal Street Partners held 123,497 shares of Bristol-Myers Squibb worth $7.12M as of Q2 2026.
Principal Street Partners sold 1,030 Bristol-Myers Squibb shares in Q2 2026, an estimated $59.1K.
Bristol-Myers Squibb made up 1.04% of Principal Street Partners's portfolio in Q2 2026, its #34 holding.
Principal Street Partners first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 28 quarters since.
Principal Street Partners's Bristol-Myers Squibb position peaked at $12.3M in Q1 2021.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Principal Street Partners's 13F filing for Q2 2026, filed 14 Aug 2026.